Antibodies directed to claudin 6, including bispecific formats thereof
US12049502B2 · kind B2 · utility
0Cited by
35References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 2023 |
| Grant date | Jul 30, 2024 |
| Priority date | — |
| Expiry date | Nov 29, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure is directed to an antibody specific for claudin 6 and CD3 and method of preparing and using the same. The present disclosure describes the isolation and characterization of antibodies, antibody fragments, and antibody variants specific for claudin 6 and CD3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.